Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
Member Profile
Florin Despa
Personal Information
Title
Associate Professor
Expertise
Cardiovascular
Institution
University of Kentucky
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
1
Progress Reports
1
Publications
8
Protocols
0
Committees
2
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
Amylin amyloid, a link between pancreas and brain pathologies in diabetes
Type-2 diabetes (T2D) is a chronic metabolic disorder that increases the risk for dementia linked to cerebrovascular disease and/or Alzheimer’s disease. Increased risk for these diseases develops years before the onset of clinically apparent T2D and is higher in people with obesity or insulin resistance. Amylin is an amyloidogenic peptide synthesized and co-secreted with insulin by pancreatic ß-cells, is elevated in obesity and pre-diabetic insulin resistance, and has binding sites in the brain regulating satiety and gastric emptying. With increased secretion, amylin forms oligomers in the secretory vesicles of pancreatic ß-cells and large amyloids extracellularly, in pancreatic islets. Accumulation of oligomerized amylin in pancreatic islets is an important source of oxidative and inflammatory stress leading to ß-cell apoptosis and development of T2D. Our preliminary data show that, in addition to plaques laden with ß-amyloid, the brain of demented T2D patients also contains large deposits of amylin. Hence, we hypothesize that hyperamylinemia contributes to the development of dementia in T2D by a steady infiltration of oligomerized amylin in cerebral vasculature and brain parenchyma. To test the association of cerebral deposition of amylin with dementia in T2D, we will now compare amylin pathology in the brain of cognitively normal T2D patients with that in cognitively impaired T2D patients and non-diabetic controls (aged =65 years) to determine how amylin concentration and distribution of amylin deposits differ from our initial findings in demented T2D patients. In a broader sample, including appropriate controls, we will assess the level of co-localization of amylin and Aß in cerebral blood vessels and brain parenchyma of demented diabetics. This research proposal exploits our laboratory’s expertise in molecular mechanisms linking hyperamylinemia with diabetic degenerative disease and the skill of UK ADC in employing human brain tissue to characterize brain responses to aging and pathological stress. If the hypothesis of toxic amylin accumulation in the cerebrovascular system and brain is proven, then hyperamylinemia could be a feasible therapeutic target to slow the neurodegenerative process in diabetic patients.
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
Amylin amyloid, a link between pancreas and brain pathologies in diabetes (Despa, Florin)
10/24/2014
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Year: 2017; Items: 2
Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia.
Ly H, Verma N, Wu F, Liu M, Saatman KE, Nelson PT, Slevin JT, Goldstein LB, Biessels GJ, Despa F
Annals of neurology
, 2017
Despa, Florin
28696548
Published
Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca(2+) leak is independent of diabetic remodeling of myocardium.
Liu M, Hoskins A, Verma N, Bers DM, Despa S, Despa F
Biochimica et biophysica acta
, 2017
Despa, Florin
29066284
Published
Year: 2016; Items: 2
Intraneuronal Amylin Deposition Peroxidative Membrane Injury and Increased IL-1ß Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
Verma N, Ly H, Liu M, Chen J, Zhu H, Chow M, Hersh LB, Despa F
Journal of Alzheimer's disease : JAD
, 2016
Despa, Florin
27163815
Published
Hyperamylinemia Increases IL-1ß Synthesis in the Heart via Peroxidative Sarcolemmal Injury.
Liu M, Verma N, Peng X, Srodulski S, Morris A, Chow M, Hersh LB, Chen J, Zhu H, Netea MG, Margulies KB, Despa S, Despa F
Diabetes
, 2016
Despa, Florin
27335231
Published
Year: 2015; Items: 2
The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells.
Guan H, Chow KM, Song E, Verma N, Despa F, Hersh LB
PLoS ONE
, 2015 (10), e0133263
Submitted Externally
26191799
Published
Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
Ly H, Despa F
Expert review of proteomics
, 2015, 1 - 3
Despa, Florin
26503000
Published
Year: 2014; Items: 2
Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model.
Despa S, Sharma S, Harris TR, Dong H, Li N, Chiamvimonvat N, Taegtmeyer H, Margulies KB, Hammock BD, Despa F
Journal of the American Heart Association
, 2014 (3)
Despa, Florin
25146704
Published
Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin.
Srodulski S, Sharma S, Bachstetter AB, Brelsfoard JM, Pascual C, Xie XS, Saatman KE, Van Eldik LJ, Despa F
Molecular neurodegeneration
, 2014 (9), 30
Despa, Florin
25149184
Published
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Cardiovascular
The DiaComp Cardiovascular Committee has the principal function of furthering the mission of the consortium with regard to diabetic cardiomyopathy and macrovascular disease.
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!